RecruitingNot ApplicableNCT04172753

Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac

Feasibility of Imaging and Radiotherapy on a Novel 1.5 T Hybrid Magnetic Resonance Imaging - Linear Accelerator System (MR-Linac)

Sponsor

University Hospital Tuebingen

Enrollment

472 participants

Start Date

May 9, 2018

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Liver Cancer Esophageal Cancer Prostate Cancer Head and Neck Cancer Rectal Cancer Oligometastasis

Summary

This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing the practical use of online MRI-guided radiation therapy using a specialized machine (called a 1.5T MR-Linac). The goal is to see how feasible it is to adapt radiation plans in real time using MRI images taken during each treatment session. **You may be eligible if...** - You are 18 or older - You have a cancer that requires radiation therapy - You are able to give informed consent **You may NOT be eligible if...** - You have a metal implant or device that is not compatible with MRI (e.g., certain pacemakers) - You have severe claustrophobia - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.